Following an independent assessment by EcoVadis—one of the world’s most respected corporate sustainability rating platforms—the “Kazakh Pharmaceutical Company MEDSERVICE PLUS” has been awarded a Silver Medal. The company scored 76 out of 100 points (94th percentile), placing it among the top 15% of companies globally assessed by EcoVadis over the past 12 months. The preparation for the EcoVadis evaluation was carried out with expert support from KPMG Caucasus and Central Asia, enabling the company to systematically strengthen its ESG practices in line with international standards.
The Silver Medal signifies a high level of maturity in implementing and advancing ESG practices aligned with globally recognized benchmarks.
“For us, this is more than just an award—it is a confirmation that we have chosen the right path toward sustainable development. We see this achievement as a collective victory for our entire team and an important step toward new, ambitious goals. We extend our special gratitude to the international pharmaceutical company AstraZeneca Kazakhstan for their fruitful cooperation, which enabled us to implement large-scale initiatives and strengthen our commitment to a sustainable future,” said Zhanat Umarov, Chairman of the Management Board of MEDSERVICE PLUS.
EcoVadis is a global leader in sustainability ratings, whose methodology is recognized by major international corporations. The EcoVadis rating is used in more than 180 countries and covers over 200 industries.
About the Company
LLP “Kazakh Pharmaceutical Company MEDSERVICE PLUS” is the largest pharmaceutical distributor in Kazakhstan with its own pharmaceutical manufacturing capabilities. The company actively implements ESG practices, including environmental projects, human capital development programs, and initiatives aimed at enhancing transparency in the supply chain. The EcoVadis recognition reinforces the company’s leadership in Kazakhstan’s pharmaceutical sector in the field of sustainable development and confirms that its ESG-driven approach is an integral part of its long-term growth strategy.
MEDSERVICE PLUS is a vertically integrated company with over 28 years of market experience and is the national leader in the distribution of pharmaceutical products in Kazakhstan. The company partners with over 320 global manufacturers and holds internationally recognized certifications for distribution, manufacturing, and pharmacy practices, including GDP, GMP, and GPP.
Its portfolio includes more than 7,900 product items, supported by 14 branches and over 1,500 employees across the country. MEDSERVICE PLUS is actively implementing advanced digital and logistics solutions (ERP SAP HANA, GxP, serialization), strictly adheres to ESG principles, and significantly contributes to the development of Kazakhstan’s pharmaceutical industry. Over the past 10 years, the company has invested more than 18 billion tenge and paid around 20 billion tenge in taxes. MEDSERVICE PLUS continues to expand its manufacturing facilities, including through strategic partnerships with investors.
The Silver Medal signifies a high level of maturity in implementing and advancing ESG practices aligned with globally recognized benchmarks.
“For us, this is more than just an award—it is a confirmation that we have chosen the right path toward sustainable development. We see this achievement as a collective victory for our entire team and an important step toward new, ambitious goals. We extend our special gratitude to the international pharmaceutical company AstraZeneca Kazakhstan for their fruitful cooperation, which enabled us to implement large-scale initiatives and strengthen our commitment to a sustainable future,” said Zhanat Umarov, Chairman of the Management Board of MEDSERVICE PLUS.
EcoVadis is a global leader in sustainability ratings, whose methodology is recognized by major international corporations. The EcoVadis rating is used in more than 180 countries and covers over 200 industries.
About the Company
LLP “Kazakh Pharmaceutical Company MEDSERVICE PLUS” is the largest pharmaceutical distributor in Kazakhstan with its own pharmaceutical manufacturing capabilities. The company actively implements ESG practices, including environmental projects, human capital development programs, and initiatives aimed at enhancing transparency in the supply chain. The EcoVadis recognition reinforces the company’s leadership in Kazakhstan’s pharmaceutical sector in the field of sustainable development and confirms that its ESG-driven approach is an integral part of its long-term growth strategy.
MEDSERVICE PLUS is a vertically integrated company with over 28 years of market experience and is the national leader in the distribution of pharmaceutical products in Kazakhstan. The company partners with over 320 global manufacturers and holds internationally recognized certifications for distribution, manufacturing, and pharmacy practices, including GDP, GMP, and GPP.
Its portfolio includes more than 7,900 product items, supported by 14 branches and over 1,500 employees across the country. MEDSERVICE PLUS is actively implementing advanced digital and logistics solutions (ERP SAP HANA, GxP, serialization), strictly adheres to ESG principles, and significantly contributes to the development of Kazakhstan’s pharmaceutical industry. Over the past 10 years, the company has invested more than 18 billion tenge and paid around 20 billion tenge in taxes. MEDSERVICE PLUS continues to expand its manufacturing facilities, including through strategic partnerships with investors.